DNTH
NASDAQ · Biotechnology
Dianthus Therapeutics Inc
$90.49
+4.46 (+5.18%)
Analyst Consensus
Strong Buy
24
Analysts
High
Coverage
Price Target
Analyst Price Target
-57.1% upside
Low Target
$27.89
Average Target
$38.82
High Target
$53.79
Current Price
$90.49
Current
$90.49
$90.49
Target
$38.82
$38.82
$27.89
$38.82 avg
$53.79
Scenario Analysis
Bear Case
$27.89
-69.2%
Low target
Base Case
$38.82
-57.1%
Avg target
Bull Case
$53.79
+-40.6%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$117.88
-23.2% from high
52-Week Low
$32.42
+179.1% from low
50-Day SMA
$90.05
+0.5% vs SMA
200-Day SMA
$85.95
+5.3% vs SMA
RSI (14)
75.2
Overbought
Target vs 52W High
$38.82
-67.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.2% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.8% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +114.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -20.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -46.0% |
| REGN | Buy | 36 | 72% | $76.80 | -91.7% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -42.6% |